Ask another

Was October 27, 2026 a new drug approved?

Today's answer →

NO

No — the latest FDA action was Oct. 26, when talazoparib plus enzalutamide got an expanded indication, not a new drug.

Why
  • Oct. 26: Talzenna plus Xtandi expanded to HRR-mutated mCSPC
  • Oct. 23: Awiqli (insulin icodec) approved for kids 10+
  • Oct. 20: Hibsago (bepirovirsen) approved for chronic hepatitis B

checked 1:55 AM · U.S. Food and Drug Administration (.gov), Optum Business, American Pharmaceutical Review, Biopharma Asia, The Script Pad, The Script Pad